Fasoracetam

DB16163InvestigationalSmall molecule

Fasoracetam is under investigation in clinical trial NCT03609619 (PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without Mglur Mutations).

Formula / weight: C₁₀H₁₆N₂O₂ · 196.25 g/mol (avg)
Code names: AEVI-001 · LAM-105 · NS-105

Resolves to

Compound

UNII42O8UF5CJBCAS110958-19-5ChEMBLCHEMBL2106179ChEBI31592KEGGC13311

Structure

InChIKeyGOWRRBABHQUJMX-MRVPVSSYSA-NSMILESO=C([C@H]1CCC(=O)N1)N1CCCCC1

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Fasoracetam, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account